Vernalis' Series A Round

Vernalis raised a round of funding on January 01, 1995. Investors include SV Health Investors.

Vernalis, formerly known as RiboTargets, is a research and development based bio-pharmaceutical company. The firm has one marketed product, frovatriptan, six product candidates in clinical trials and …

Articles about Vernalis' Series A Round: